Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. G. (Gert) Luurtsema

Research interests

The research of Gert Luurtsema, associate professor at the UMCG, is focused on a broad range of topics, ranging from tracer development to validation of clinical imaging applications. With support of NWO-STW funding, he has accomplished a research line on imaging of the blood-brain barrier (BBB) integrity in relation to brain disorders and drug delivery. Besides this, he is supervising > 7 PhD students, 5 master students and 3 postdocs. Currently, he is (co-)author of more than 100 peer-reviewed scientific articles in high ranking journals and scientific textbooks. He was guest editor of the journals Current Pharmaceutical Design and Contrast Media & Molecular Imaging. 


[15O]H2O PET: Potential or Essential for Molecular Imaging?

Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer

Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies

Oral administration of PET tracers: Current status

Quantification of P-glycoprotein function at the human blood-brain barrier using [ 18F]MC225 and PET.

Severely increased albuminuria in patients with type 2 diabetes mellitus is associated with increased subclinical atherosclerosis in femoral arteries with Na [18F]F activity as a proxy: The DETERMINE study

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET

Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [ 18 F]MC225 and PET

Methods and equipment for quality control of radiopharmaceuticals

[18F]MC225 PET for the dose-response assessment of tariquidar inhibition of blood-brain barrier P-glycoprotein function in vivo

Read more


Diagnosi di malattie cerebrali oggi se ne parla a Triggiano

Diagnose van prostaatkanker bij Treant op topniveau